Abstract
Twenty-two patients with arthritis received 5 gm. of glycocyamine and 20.16 gm. of betaine by mouth daily, in hospital and after discharge, for periods ranging from 13 to 42 days. A control group of 22 patients, indistinguishable from the treated group, were maintained on the same regimen and given placebos resembling the agents under study.
The condition of each patient was evaluated clinically before, during and after treatment, and x-ray and metabolic studies were made. No significant improvement attributable to the use of the drugs was observed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BORSOOK H., BORSOOK M. E. The biochemical basis of betaine-glycocyamine therapy. Ann West Med Surg. 1951 Oct;5(10):825–829. [PubMed] [Google Scholar]
- BORSOOK M. E., BORSOOK H. Treatment of cardiac decompensation with betaine and glycocyamine. Ann West Med Surg. 1951 Oct;5(10):830–855. [PubMed] [Google Scholar]
- GRAYBIEL A., PATTERSON C. A. Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report. Ann West Med Surg. 1951 Oct;5(10):863–875. [PubMed] [Google Scholar]
- GREINER T., GOLD H., CATTELL M., TRAVELL J., BAKST H., RINZLER S. H., BENJAMIN Z. H., WARSHAW L. J., BOBB A. L., KWIT N. T. A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin). Am J Med. 1950 Aug;9(2):143–155. doi: 10.1016/0002-9343(50)90017-9. [DOI] [PubMed] [Google Scholar]
- VAN ZANDT V., BORSOOK H. New biochemical approach to the treatment of congestive heart failure. Ann West Med Surg. 1951 Oct;5(10):856–862. [PubMed] [Google Scholar]